Pharmacological properties of complex iron oxide nanoparticles entering in magnetic resonance tomography contrast agent

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 73, Issue 6, 2010, Pages 23-28

  Akopdzhanov, A G ^a   Sergeev, A I ^b   Manvelov, E V ^a   Semeikin, A V ^a   Naumenko, V Yu ^a   Panov, V O ^a   Bykov, I V ^a   Shimanovskii, N L ^a  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b SEMENOV INSTITUTE OF CHEMICAL PHYSICS   (Russian Federation)

Author keywords

Cytotoxicity; Iron oxide nanoparticles; Magnetic resonance tomography

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; CONTRAST MEDIUM; FERRIC ION; FERRIC OXIDE; NANOPARTICLE;

ARTICLE; COLLOID; CYTOTOXICITY; HELA CELL; NUCLEAR MAGNETIC RESONANCE; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BRAIN; HELA CELL LINE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; RADIOGRAPHY; RAT; SYNTHESIS;

ANIMALS; BRAIN; CONTRAST MEDIA; FERRIC COMPOUNDS; HELA CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; RATS;

EID: 77955411123     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. A. E. Neuwelt, B. E. Hamilton, et al, Kidney International, 75, 465-474 (2009).
2. I. S. Jacjbs and C. P Bean, In Magnetism, Academic Press, New York (1963), 3, p. 271.
3. Kin Man Ho and Pei Li, American Chemical Society, 24(5), 1801-1807 (2008).
4. D. Kumar, J. Narayan, A. V. Sharma, and J. Sankar, J. Magn. Magn. Mater., 232, 161 (2001).
5. X. Li, X. Du, T. Huo, et al., Acta Radiol, 50(6), 583-594 (2009).
6. I. Martinez-Mera, M. E. Espinoza-Pesqueira., R. Perez-Hernandez, and J. Arenas-Alatorre, Materials Letters, 61, 4447-4451 (2007).
7. F. C. Meldrum, N. A. Kotov, and J. H. Feodler, American Chemical Society, 98, 4506-4510 (1994).
8. S. C. Pang, S. F. Chin, and M. A. Anderson, J. Colloid and Interface Sci., 311, 94-101 (2007).
9. M. Taupitz, S. Wagner, J. Schnorr, et al., Investigative Radiology, 39, 394-405 (2004).